Lazard Asset Management’s Huntsman Corp HUN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-106,489
Closed -$1.11M 2044
2025
Q2
$1.11M Buy
+106,489
New +$1.3M ﹤0.01% 1269
2025
Q1
Sell
-62,560
Closed -$1.13M 2422
2024
Q4
$1.13M Buy
+62,560
New +$1.3M ﹤0.01% 1107
2023
Q2
Sell
-115
Closed -$3K 2406
2023
Q1
$3K Sell
115
-3,637
-97% -$108K ﹤0.01% 2186
2022
Q4
$103K Sell
3,752
-2,433
-39% -$66.2K ﹤0.01% 1527
2022
Q3
$151K Sell
6,185
-159,556
-96% -$4.48M ﹤0.01% 1335
2022
Q2
$4.7M Buy
165,741
+104,493
+171% +$3.53M 0.01% 750
2022
Q1
$2.3M Buy
61,248
+59,605
+3,628% +$2.24M ﹤0.01% 876
2021
Q4
$57K Buy
+1,643
New +$53.6K ﹤0.01% 1681
2019
Q3
Sell
-383,399
Closed -$7.84M 1513
2019
Q2
$7.84M Buy
383,399
+31,968
+9% +$671K 0.01% 508
2019
Q1
$7.9M Sell
351,431
-4,096
-1% -$92.2K 0.01% 496
2018
Q4
$6.86M Buy
355,527
+203,176
+133% +$4.36M 0.01% 475
2018
Q3
$4.15M Buy
152,351
+3,774
+3% +$115K 0.01% 597
2018
Q2
$4.34M Buy
148,577
+140,899
+1,835% +$4.36M 0.01% 584
2018
Q1
$224K Buy
+7,678
New +$251K ﹤0.01% 834

Other funds holding HUN

Lazard Asset Management's HUN Position: Q3 2025 in Review

Lazard Asset Management sold out of Huntsman Corp (HUN) in Q3 2025, closing a stake of 106,489 shares — an estimated $1.11M sold.

Lazard Asset Management first reported a position in HUN in Q1 2018 and held it in 14 quarters. The position peaked at $7.9M in Q1 2019. 350 funds tracked by Wall St. Rank hold HUN as of Q3 2025.

  • Lazard Asset Management reported no remaining Huntsman Corp position as of Q3 2025 after selling out during the quarter.
  • Lazard Asset Management sold 106,489 Huntsman Corp shares in Q3 2025, an estimated $1.11M.
  • Lazard Asset Management first reported a position in Huntsman Corp in Q1 2018 and held it in 14 quarters.
  • Lazard Asset Management's Huntsman Corp position peaked at $7.9M in Q1 2019.
  • 350 funds tracked by Wall St. Rank held Huntsman Corp as of Q3 2025.

Based on Lazard Asset Management's 13F filing for Q3 2025, filed 14 Nov 2025.